PhD, School of Life Sciences, Peking University
China Europe International Business School EMBA
In 2011, Dr. Jiang Zhi co-founded Nuohe Zhiyuan as the president. By 2018, Nuohe Zhiyuan has developed into the world's largest high-throughput sequencing and bioinformatics service company, and submitted a GEM listing application in 2018;
The Nuohe Medical team was established in 2015, and the first batch of high-throughput sequencing oncology diagnostic services was launched in China, and the first batch of second-generation sequencing oncology diagnostic products CFDA registration certificates were obtained in 2018;
In 2018, he became the CEO of Golden Key Medicine and is responsible for the overall management of the company.
Jiang Zhi is a representative of the Tianjin People's Congress, a senior senior researcher, and a high-end leader in Zhongguancun. He has published 26 articles and applied for 23 invention patents. As the person in charge of the project, he has undertaken projects such as the National Natural Science Foundation of China, the Beijing Municipal Science and Technology Commission Innovation Research, the Beijing Science and Technology Commission Pharmaceutical Cooperative Science and Technology Innovation Research, the Tianjin Major Science and Technology Project, and the Tianjin Science and Technology Bureau Biomedical Engineering Science and Technology Major Project.
Beijing：A202 Innovation Building, Changping Life Garden, Beijing
Tianjin：Building B21, Pioneering Headquarters Base, Wuqing District, Tianjin
Shanghai：1st Floor, Building 2, Xiangyun Technology Park, Jiading District, Shanghai
Guangzhou：F3,B8,Scientific Industry Accerator,No.11,Kaiyuan Ave,Huangpu District,Guangzhou
GensKey. All Rights Reserved.